$CGEN 4 SEC Filings

Filed On	Filing
30 Jul 2026	Form 4: Levine Zurit, SVP, Business Development Received 18,000 shares as a grant or award · Granted 24,000 Share Option (right to buy)
30 Jul 2026	Form 4: Silberman David, Chief Financial Officer Received 19,500 shares as a grant or award · Granted 26,000 Share Option (right to buy)
30 Jul 2026	Form 4: Ophir Eran, Director Granted 200,000 Share Option (right to buy)
30 Jul 2026	Form 4: Cohen-Dayag Anat, Director Granted 100,000 Share Option (right to buy)
30 Jul 2026	Form 4: Perry Eran, Director Received 7,500 shares as a grant or award · Granted 10,000 Share Option (right to buy)
30 Jul 2026	Form 4: Ferre Pierre, Chief Operating Officer Granted 70,000 Share Option (right to buy)
30 Jul 2026	Form 4: Kredo Russo Sharon, SVP, Research & Discovery Received 18,000 shares as a grant or award · Granted 24,000 Share Option (right to buy)
30 Jul 2026	Form 4: Livnat Savitzky Kinneret, Director Received 7,500 shares as a grant or award · Granted 10,000 Share Option (right to buy)
30 Jul 2026	Form 4: Hukkelhoven Mathias, Director Received 7,500 shares as a grant or award · Granted 10,000 Share Option (right to buy)
30 Jul 2026	Form 4: Halevy Gilead, Director Received 7,500 shares as a grant or award · Granted 10,000 Share Option (right to buy)
30 Jul 2026	Form 4: Zweifach Sanford S, Director Received 7,500 shares as a grant or award · Granted 10,000 Share Option (right to buy)
30 Jul 2026	Form 4: Mahler Michelle, Chief Medical Officer Received 13,500 shares as a grant or award · Granted 18,000 Share Option (right to buy)
13 Jul 2026	Form 4: Levine Zurit, SVP, Business Development Received 1,875 shares by exercise or conversion ($1.55K) · Sold 1,875 shares ($4.69K)
27 Apr 2026	Form 4: Levine Zurit, SVP, Business Development Received 2,000 shares by exercise or conversion ($2.3K) · Sold 2,000 shares ($6.4K)
27 Apr 2026	Form 4: Ophir Eran, Director Received 5,000 shares by exercise or conversion ($4.15K) · Sold 5,000 shares ($16K)
15 Apr 2026	Form 4: Ophir Eran, Director Received 5,000 shares by exercise or conversion ($4.15K) · Sold 5,000 shares ($14.5K)
15 Apr 2026	Form 4: Levine Zurit, SVP, Business Development Received 2,000 shares by exercise or conversion ($2.3K) · Sold 2,000 shares ($5.6K)
13 Apr 2026	Form 4: Levine Zurit, SVP, Business Development Received 3,125 shares by exercise or conversion ($3.23K) · Sold 3,125 shares ($8.01K)
09 Apr 2026	Form 4: Levine Zurit, SVP, Business Development Received 2,500 shares by exercise or conversion ($2.07K) · Sold 2,500 shares ($5.75K) · Received 5,375 shares by exercise or conversion ($4.78K) · 1 more
03 Apr 2026	Form 4: Levine Zurit, SVP, Business Development Received 3,500 shares by exercise or conversion ($3.22K) · Sold 3,500 shares ($7.7K)

Comments